Skip to content

Exercise Performance in Patients With Atrial Fibrillation

Exercise Performance in Patients With Atrial Fibrillation: Usefulness of Cardiopulmonary Exercise Test

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01943981
Acronym
AF-CPX
Enrollment
50
Registered
2013-09-17
Start date
2013-09-30
Completion date
Unknown
Last updated
2013-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Heart failure and stroke are the two major complication of atrial fibrillation. Current treatment for atrial fibrillation is so focused to stroke prevention, but the risk assessment for heart failure is less highlighted. The most of patients with atrial fibrillation have cardiac functional limitation of variable degree. We hypothesize that the exercise test would reveal the subclinical cardiac dysfunction, and might be helpful to classify the patients with atrial fibrillation according to their exercise capacity real cardiac function.

Interventions

None listed

Sponsors

Incheon St.Mary's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Nonvalvular chronic atrial fibrillation * Left ventricular ejection fraction \>40%

Exclusion criteria

* Acute decompensated heart failure within 30 days * unstable hemodynamic status * Significant coronary artery disease * Any condition interfering sufficient exercise * Valvular stenosis or regurgitation of moderate or severe degree * Obstructive or restrictive lung disease of moderate or severe degree * Active malignancy

Design outcomes

Primary

MeasureTime frame
Exercise response patterns of heart rate and oxygen uptakeAt baseline

Secondary

MeasureTime frame
Composite cardiovascular events (all death, admission of heart failure, stroke/thromboembolism)Up to 2 years

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026